NCT03255512 - Vericiguat Drug-drug Interaction Study With Isosorbite Mononitrate in Stable Coronary Artery Disease Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 17, 2017

Primary Completion Date

February 7, 2018

Study Completion Date

March 23, 2018

Conditions

Coronary Artery Disease

Interventions

DRUG

Vericiguat (BAY1021189)

2.5 mg/tablet; 5 mg/tablet or 10 mg/tablet

DRUG

Placebo

Matching placebo

DRUG

Isosorbide mononitrate (ISMN)

30 mg/tablet or 60 mg/tablet

Trial Locations (6)

Charité - Campus Virchow-Klinikum (CVK), Berlin

Universitätsklinikum Hamburg Eppendorf (UKE), Hamburg

Medizinische Einrichtungen der Universität Bonn, Bonn

Universitätsklinikum Heidelberg, Heidelberg

Universitätsherzzentrum Freiburg - Bad Krozingen, Bad Krozingen

SocraTec R&D GmbH, Erfurt